Delivery Order SPE2DB25D3504-SPE2DB25FVUND
Award Date 5/1/25
Potential Completion Date 5/2/25
Potential Value $1.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Briviact 100 mg tablets (60-count packages) with a ceiling value of $1,067.55. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside designation, and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Briviact 100 mg tablets in quantities of 60 units, with a ceiling value of $2,859.99. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 20, 2025. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $5,677.12 to AmerisourceBergen Drug Corp for the supply of Briviact 100 mg tablets (60-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitive, non-set-aside award employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 1, 2025, for the supply of Briviact 100 mg tablets (60-count unit) under a firm fixed-price contract valued at $1,498.21. This is a non-set-aside competitive award with a completion date of May 2, 2025, and performance location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Briviact 100 mg tablets (60-count) at a firm fixed price of $2,788.43, with an ultimate completion date of May 7, 2025. This is a competitively awarded, non-set-aside delivery order executed under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 pharmaceutical supply agreement running through...
- The Defense Logistics Agency awarded a delivery order valued at $9,365.70 to AmerisourceBergen Drug Corp for the supply of Briviact 50 mg tablets (60-count units). This firm fixed-price, non-competitive delivery order was executed on September 26, 2025, with an ultimate completion date of September 29, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Briviact 75 mg tablets (60-count units) under a firm fixed price contract valued at $2,124.38, with an ultimate completion date of October 20, 2025. This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement extending through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Briviact 10 mg/mL oral solution in a 300 mL quantity, with a ceiling value of $2,116.72. This competitively awarded, firm fixed-price delivery order is set to be completed by August 13, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Briviact 50 mg tablets (60-count units) with a ceiling value of $3,639.16. This is a firm fixed-price delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle valued through December 2026. The award was competitively granted with no set-aside designation...
- The Defense Logistics Agency awarded a delivery order valued at $2,320.35 to AmerisourceBergen Drug Corp for Briviact 50 mg tablets (60-count supply) on September 26, 2025, with an ultimate completion date of September 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...